Sensus Healthcare Gestione
Gestione criteri di controllo 4/4
Sensus Healthcare Il CEO è Joe Sardano, nominato in Jun2010, e ha un mandato di 14.42 anni. la retribuzione annua totale è $ 687.60K, composta da 65.4% di stipendio e 34.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 7.17% delle azioni della società, per un valore di $ 8.09M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.3 anni e 7.8 anni.
Informazioni chiave
Joe Sardano
Amministratore delegato
US$687.6k
Compenso totale
| Percentuale dello stipendio del CEO | 65.4% |
| Mandato del CEO | 14.4yrs |
| Proprietà del CEO | 7.2% |
| Durata media del management | 3.3yrs |
| Durata media del Consiglio di amministrazione | 7.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares
Nov 12
At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?
Oct 03Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up
May 12Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$7m |
| Mar 31 2024 | n/a | n/a | US$5m |
| Dec 31 2023 | US$688k | US$450k | US$485k |
| Sep 30 2023 | n/a | n/a | -US$896k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$754k | US$400k | US$24m |
| Sep 30 2022 | n/a | n/a | US$27m |
| Jun 30 2022 | n/a | n/a | US$25m |
| Mar 31 2022 | n/a | n/a | US$21m |
| Dec 31 2021 | US$628k | US$375k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$181k |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$510k | US$375k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$467k | US$375k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$538k | US$360k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$490k | US$324k | -US$4m |
Compensazione vs Mercato: La retribuzione totale di Joe ($USD 687.60K ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 650.91K ).
Compensazione vs guadagni: La retribuzione di Joe è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Joe Sardano (71 yo)
14.4yrs
Mandato
US$687,599
Compensazione
Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$687.60k | 7.17% $ 8.1m | |
| President | 7.8yrs | US$452.53k | 0.46% $ 514.9k | |
| Chief Financial Officer | 4.8yrs | US$357.06k | 0.25% $ 276.9k | |
| Chief Operating Officer | 1.8yrs | Nessun dato | 0.060% $ 67.1k | |
| Chief Technology Officer | 1.8yrs | Nessun dato | 0.061% $ 68.8k | |
| Vice President of Marketing | 1.8yrs | Nessun dato | Nessun dato |
3.3yrs
Durata media
46yo
Età media
Gestione esperta: Il team dirigenziale di SRTS è considerato esperto (durata media dell'incarico 3.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 14.4yrs | US$687.60k | 7.17% $ 8.1m | |
| President | less than a year | US$452.53k | 0.46% $ 514.9k | |
| Independent Director | 8.3yrs | US$75.00k | 0.28% $ 319.7k | |
| Member of Medical Advisory Board | 7.8yrs | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | 7.8yrs | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | 7.8yrs | Nessun dato | Nessun dato | |
| Independent Director | 9.1yrs | US$75.00k | 0.061% $ 68.8k | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | 7yrs | Nessun dato | Nessun dato | |
| Member of the Medical Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | no data | Nessun dato | Nessun dato |
7.8yrs
Durata media
71yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SRTS sono considerati esperti (durata media dell'incarico 7.8 anni).